
|Articles|February 11, 2008
Latebreakers: New recombinant injection approved for growth failure
Sandoz's Omnitrope Pen 5 has been cleared for treating kids with growth failure and adults with growth hormone deficiency on a long-term basis
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
2
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
3
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
4


























































































































































